Simulations Plus (NASDAQ:SLP) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of – for the period. The company issued revenue guidance of $47.83 million-$49.91 million, compared to the consensus revenue estimate of $50.48 million.
SLP traded down $1.92 during midday trading on Tuesday, reaching $57.53. The company’s stock had a trading volume of 173,974 shares, compared to its average volume of 210,639. The company has a fifty day simple moving average of $64.09 and a 200 day simple moving average of $68.82. Simulations Plus has a twelve month low of $36.22 and a twelve month high of $90.92. The stock has a market cap of $1.16 billion, a P/E ratio of 116.57, a PEG ratio of 8.45 and a beta of -0.07.
Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Sunday, April 11th. The technology company reported $0.15 EPS for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.01. Simulations Plus had a return on equity of 10.65% and a net margin of 22.74%. As a group, sell-side analysts expect that Simulations Plus will post 0.57 earnings per share for the current year.
A number of analysts have commented on SLP shares. Zacks Investment Research downgraded Simulations Plus from a hold rating to a sell rating in a research report on Friday, April 16th. Craig Hallum reduced their price objective on Simulations Plus from $81.00 to $74.00 and set a hold rating for the company in a research report on Tuesday, April 13th. Oppenheimer raised their price objective on Simulations Plus from $79.00 to $85.00 in a research report on Tuesday, January 12th. Finally, TheStreet upgraded Simulations Plus from a c+ rating to a b rating in a research report on Friday, January 8th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. Simulations Plus presently has a consensus rating of Hold and an average target price of $80.20.
In related news, Director David L. Ralph sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 11th. The stock was sold at an average price of $84.34, for a total transaction of $421,700.00. Also, Director Walter S. Woltosz sold 24,000 shares of Simulations Plus stock in a transaction on Monday, February 22nd. The shares were sold at an average price of $73.01, for a total value of $1,752,240.00. Insiders have sold a total of 77,000 shares of company stock valued at $5,259,860 in the last 90 days. 24.45% of the stock is owned by corporate insiders.
A hedge fund recently bought a new stake in Simulations Plus stock. OLD Mission Capital LLC acquired a new position in Simulations Plus, Inc. (NASDAQ:SLP) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,100 shares of the technology company’s stock, valued at approximately $309,000. 60.75% of the stock is owned by institutional investors and hedge funds.
About Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments.
See Also: Understanding Market Liquidity
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.